In a retrospective registry study of 154 consecutive patients suffering from acute myocardial infarct complicated by cardiogenic shock who underwent PCI with Impella support, Dr . William O Neill et al . reported that those patients who had Impella support initiated prior to PCI had significantly increased survival compared to those who had Impella support initiated after PCI . ?/s>In April 2016, the Impella 2.5, Impella CP, Impella 5.0, and Impella LD received FDA PMA to provide treatment of ongoing cardiogenic shock for periods up to 4 days in the case of the Impella 2.5 " ! and Impella CP " ! and for periods up to 6 days in the case of the Impella 5.0 " ! and Impella LD " !.
